CMV (Cytomegalovirus) by IHC
Use
Immunohistochemistry (IHC)–based detection of cytomegalovirus (CMV), an opportunistic pathogen that infects lung, kidney, gut, and other organs, particularly in immunologically immature individuals such as fetuses and neonates, as well as in immunosuppressed patients including transplant recipients, chemotherapy patients, and people with HIV.
Special Instructions
Not provided.
Limitations
Not provided.
New York Approved
Methodology
Immunoassay (IHC)
Biomarkers
CMV
Protein
Result Turnaround Time
1-2 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (FFPE)
Volume
Not provided
Minimum Volume
Not provided
Collection Instructions
FFPE tissue block preferred, or one unbaked unstained H&E slide plus two to three positively charged unstained slides (4–5 µm cuts) per test/antibody; block and slide identifiers must match requisition.
Storage Instructions
Use cold pack for transport; ensure cold pack is not in direct contact with specimen. NYS clients provide date and time of collection.